ResMed (ASX:RMD) acquired VirtuOx, a US-based diagnostic testing provider for sleep, respiratory, and cardiac conditions, according to a Thursday statement by the company.
Under the deal, VirtuOx will operate as the company's unit and offer its at-home diagnostic services, per the statement.
Financial terms of the deal were not disclosed, with the company stating the acquisition is not material to its financial results.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.